Headache Conference

Blue and green synapses outline a shape of the brain.

This event took place on October 3, 2020

Target Audience

Neurologists, internal medicine, and family medicine physicians, physician assistants, nurse practitioners, and others who treat or manage patients with headache disorders.

Learning outcome/objectives

After the symposium, participants should be able to:

  • Recognize uncommon headache syndrome and their respective treatment
  • Improve approach and treatment of facial pain and sinus headache
  • Improve our understanding of sleep disorder
  • Learn about available behavioral approaches to headache disorders
  • Summarize new advances in headache therapy


7:50  8 a.m.      Welcome & Opening Remarks

8 – 8:45             Uncommon headache syndrome: diagnosis and treatment
                           Emily Riddle, M.D., Headache Medicine, OHSU Neurology

8:45 – 9:30       Approach to headache management during COVID pandemic
                           Juliette Preston, M.D., Headache Medicine, OHSU Neurology

9:30 10:15      Sleep disorders: approach and treatment
                            Asha Singh, M.D., Sleep Medicine, OHSU Neurology

10:15 – 10:30    Break

10:30 – 11:15    Behavioral approaches to headache disorders
                            Daniel Krashin, M.D., Psychiatry, Veteran Affairs, Washington

11:15 – 12:15    New and emerging therapies in Headache Medicine
                            Natalia Murinova, M.D., Headache Medicine, University of Washington

12:15 – 12:30    Closing Remarks

Thank you to our Premium Exhibitors


  • Allergan an AbbVie Company
  • Teva Pharmaceuticals
  • Upsher-Smith Laboratories, LLC


  • Amgen/Novartis

Additional information

Accreditation: The School of Medicine, Oregon Health & Science University (OHSU), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: Oregon Health & Science University School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Providers should claim only the credit commensurate with the extent of their participation in the activity.

Please contact Dina Girgenti-Iida (971 244-2189)with questions.